Literature DB >> 9135995

Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.

L Liu1, A M Goldstein, M A Tucker, H Brill, N A Gruis, D Hogg, N J Lassam.   

Abstract

Mutations in the gene encoding the cell cycle inhibitor CDKN2A have been identified in some melanoma kindreds linked to 9p21. However, many such families show no evidence of mutations in the coding regions of CDKN2A. In this study, we examined whether two other potential tumor suppressors, CDKN2B and p19ARF, which also map within the 9p21 region, play a role in the development of familial melanoma. We found no mutations in the coding regions of either gene in melanoma-prone families with evidence of linkage to 9p21. We conclude either that another melanoma susceptibility gene exists within this chromosomal area or that mutations in noncoding regions of CDKN2A, CDKN2B, or p19ARF predispose to melanoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135995

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Xueying Liang; Ruth M Pfeiffer; William Wheeler; Dennis Maeder; Laurie Burdette; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.

Authors:  K Laud; C Marian; M F Avril; M Barrois; A Chompret; A M Goldstein; M A Tucker; P A Clark; G Peters; V Chaudru; F Demenais; A Spatz; M W Smith; G M Lenoir; B Bressac-de Paillerets
Journal:  J Med Genet       Date:  2005-06-03       Impact factor: 6.318

Review 3.  New developments in melanoma genetics.

Authors:  N Hayward
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

4.  Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.

Authors:  N Soufir; B Bressac-de Paillerets; L Desjardins; C Lévy; J Bombled; I Gorin; P Schlienger; D Stoppa-Lyonnet
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

5.  Mutation testing in melanoma families: INK4A, CDK4 and INK4D.

Authors:  J A Newton Bishop; M Harland; D C Bennett; V Bataille; A M Goldstein; M A Tucker; B A Ponder; J Cuzick; P Selby; D T Bishop
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

6.  Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.

Authors:  G Palmieri; A Cossu; P A Ascierto; G Botti; M Strazzullo; A Lissia; M Colombino; M Casula; C Floris; F Tanda; M Pirastu; G Castello
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.